Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Reacx Pharmaceuticals, Inc.

Clinical trials sponsored by Reacx Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New implant could help fight opioid addiction – safety trial begins Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New implant could help fight opioid addiction – safety trial begins

Disease control Recruiting now

This early-stage study tests the safety of nalmefene implants in 24 healthy adults. Participants receive one or two implants that stay in place for 4 or 12 weeks. Researchers monitor side effects and how the drug moves through the body to plan future studies in people with opioid…

Phase 1 • Sponsor: ReacX Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC